bumping this back to the top in case anyone missed it also while i'm at it here -- do any of you guys have any ideas how we could go about getting more visibility for these threads? and really just more visibility for Stockaholics in general? i realize we're in the dog days of the summer right now and things are naturally pretty dead/quiet out there during this time of the year ... but i remember we were still getting 20+ participants back in the days during the summer in previous years ... not really sure what happened here but it would be great to hear what, if any ideas you guys have for bringing in more visibility for the above threads as well as for the Stockaholics boards in general! thx in advance
Early movers: YHOO, VZ, CKEC, AGN, KLB, HSY, TSLA, SCTY, AAPL & more Yahoo — Verizon is buying Yahoo's operating businesses for $4.8 billion in cash. The deal does not include Yahoo's stakes in Alibaba and Yahoo Japan, and also excludes certain patents and Yahoo's cash. Carmike Cinemas — The movie theater chain will be bought by rivalAMC Entertainment in an improved deal worth $33.06 per share in cash and stock — that's a more than 10 percent improvement over AMC's original bid. Allergan — Credit Suisse initiated coverage on Allergan with an "outperform" rating, saying the drug maker has a broad and underappreciated pipeline. Kimberly-Clark — The consumer products maker reported quarterly profit of $1.56 per share, eight cents a share above estimates. Revenue also beat Street forecasts. The company said it performed well in a challenging economic environment. Hershey — The Hershey Trust — the chocolate maker's largest shareholder — agreed to make significant governance changes, according to Dow Jones. Those changes could potentially boost the chances that a previously rejected $23 billion takeover offer fromMondelez International will be in play once again. Tesla, SolarCity — The two are close to striking a merger deal, according to a Reuters report. Both the automaker and the solar company are controlled by billionaire Elon Musk. G-III Apparel — G-III struck a deal to buy Donna Karan International from LVMH, in a transaction worth $650 million. Apple — Apple is expected to sell its one billionth iPhone this week, according to the Financial Times. Tableau Software — Tableau was downgraded to "hold" from "buy" at Deutsche Bank, which said price discounting and competition could weigh shares of Tableau, which specializes in data analysis and sharing. Viacom — Viacom saw its Paramount studio film "Star Trek Beyond" top the weekend box office, with North American ticket sales of $59.6 billion. Ericsson — Chief Executive Officer Hans Vestberg resigned effective immediately, according to the telecom equipment maker. He had been under fire for the past few months, due in large part to weak financial results. Dow Chemical, DuPont — The two companies are offering concessions to the European Union in order to win approval from their planned merger deal, according to a Bloomberg report. Salesforce.com — Salesforce CEO Marc Benioff told LinkedIn that he might have been willing to pay much more for the company than the $26 2 billion that Microsoft paid, had he been given the chance. That's according to a Re/code report. Danaher — The designer and manufacturer of industrial and consumer products beat estimates by three cents a share, with adjusted quarterly profit of $1.25 per share. Revenue also came in above forecasts. The company said it did well in what it calls "challenging" economic conditions.
Allergen -- AGN is worth watching. Back in May, after the sale to Teva, the company announced a ginormous $10B stock buyback program. $4 - $5B will be bought over the next 4 to 6 months until the strcuture is exhausted. Banks are sure to play nice with the company. Nearing a major breakout point at $248.75. Botox is a thriving business. Everyone wants Botox. The sad part is people using it look ugly as hell. They don't even look like themselves. I am not kidding. People (humans) start resembling their descendants -- apes.
Love that comment. Many hold a point of view that LinkedIn has no value to MSFT's business but those that think that are not aware of MSFT's enterprise CRM software business that is a fair chunk of MSFT's revenue. MSFT would have lost a bidding war to SalesForce so glad it never happened.
Early movers: DD, MMM, VZ, UTX, SBUX, BUD, GILD, BA & more DuPont — DuPont earned an adjusted $1.24 per share for the second quarter, 14 cents a share above estimates. Revenue was also above forecasts and the chemical maker also raised its full-year forecast. DuPont had stronger sales in agriculture and other areas, as well as expanded profit margins. 3M — 3M earned $2.08 per share for the second quarter, beating estimates by one cent a share. Revenue came in shy of Street forecasts, and the company lowered its sales growth guidance for 2016. Caterpillar — The heavy equipment maker beat estimates by 13 cents a share, with quarterly profit of $1.09 per share. Revenue beat forecasts, as well. However, it continues to feel the impact of a decline in the mining industry. Verizon — The telecommunications giant beat estimates by two cents a share, with adjusted quarterly profit of 94 cents per share. Revenue missed forecasts. Verizon said its results were hurt by a seven-week workers strike. United Technologies — The industrial conglomerate reported adjusted quarterly profit of $1.82 per share, 14 cents a share above estimates. Revenue also beat forecasts and United Technologies raised its full-year forecast, as well. Under Armour — The athletic apparel maker matched estimates with profit of one cent per share, and revenue was essentially in line, as well. Under Armour's bottom line showed a 28 percent improvement from a year earlier on greater demand for apparel and basketball shoes. Starbucks — The coffee chain's stock was added to the "Americas Conviction List" at Goldman Sachs, which said it sees Starbucks comparable-store sales re-accelerating into the fiscal fourth quarter. Eli Lilly — The drugmaker's earnings matched estimates at 86 cents per share, with revenue above forecasts. Lilly's results were helped by demand for cancer and diabetes treatments. Gilead Sciences — The drugmaker reported adjusted quarterly profit of $3.08 per share for its latest quarter, beating estimates by six cents a share. Revenue was essentially in line, but investors may focus on Gilead's lower full-year sales outlook. The company pointed to slower-than-expected sales of its hepatitis C drugs. Anheuser-Busch InBev — The company raised its offer for rival beer brewer SABMiller, in a bid to relieve concerns related to the falling value of the British pound. The offer is now 2.2 percent higher and also increases the cash portion of the deal. Las Vegas Sands — Las Vegas Sands missed estimates by four cents a share, with adjusted quarterly profit of 52 cents per share. The casino operator's revenue also missed forecasts. Las Vegas Sands was hurt by continuing declines in its Macau operations. Texas Instruments — Texas Instruments came in four cents a share ahead of Street forecasts, with quarterly profit of 76 cents per share. The chipmaker's revenue also exceeded estimates. The company saw particular strength in its automotive and communications chip segments, among others. Celgene — Celgene said its Revlimid drug did not extend survival rates in a trial involving a type of blood cancer, and that the drugmaker would not seek approval for the drug for that use. Goldman Sachs — Goldman will be the subject of an enforcement action by the Federal Reserve, according to The New York Times. The case relates to a leak of confidential information, and will reportedly include a penalty of less than $50 million. BP — BP reported lower-than-expected profit for the second quarter due to weaker oil prices and lower profit margins for refining, prompting the oil giant to cut its planned 2016 capital spending budget. Boeing — Boeing was accused by major supplier Rockwell Collins of being delinquent in its payments, saying the jet maker is behind on tens of millions of dollars in bills due at the end of last month. Boeing issued a statement saying it was in the process of adjusting payment terms with suppliers to align with current industry norms. Noodles & Company, Red Robin Gourmet Burgers — Jefferies downgraded a number of restaurant chain stocks to "hold" from "buy," including Noodles and Red Robin Gourmet Burgers. Jefferies cites too much capacity and a tight labor market.
$ES_F #ES_F #SPY levels to watch 2174.50 / / 2162.75 $CL_F #CL_F #crudeoil levels to wtach 43.12 / / 42.31 / / 41.49
buckle up here we go with some big name ER after the market close today: $AAPL $TWTR $X $BWLD $MTCH $EW $AKAM $ILMN $PNRA $CTXS $IRBT $JNPR $APC $CB
here's some names reporting in the pre-market tomm. $BA $KO $MO $LL $TMUS $CMCSA $GD $GLW $LVLT $NOC $DPS $SIX $FCAU $ARMH $WM $WYN
